Agenda - Thursday 15 November 2018

Please select the stream you wish to view

08:30 - 09:30

Registration

09:30 - 10:00

Keynote – Excellence across the care pathway: NICE and diabetes

NICE has produced over 40 pieces of guidance, advice and quality standards on every conceivable element of diabetes prevention, treatment and management. Find out how NICE’s recommendations are developed, and how they could help you to commission and provide high quality, person-centred care.

Chair, NICE (National Institute for Health and Care Excellence)
10:05 - 10:35

ADA/EASD guidelines: Where do the SIGNs send us? Are the messages NICE?

Following the publication of the ADA/EASD guidelines for the Management of Hyperglycaemia in Type 2 Diabetes at EASD in 2018, Dr Seidu explores how these guidelines should impact the management of diabetes in the UK? Do the guidelines support the recommendations from SIGN and what update is needed from NICE? Learning outcomes: A chance to…

GP Partner, UG Tutor, Primary Care Research Fellow, Hockley Farm Medical Practice, University of Leicester, Leicester Diabetes Centre
10:40 - 11:10

Individualising diabetes care for older people with a focus on frailty

Care for older people with diabetes has unique challenges.  Multiple comorbidities associated with ageing combined with the increased prevalence of geriatric syndromes and frailty contributes to the complexity of managing diabetes in older people.  Comprehensive geriatric assessment should be performed on the initial diagnosis of diabetes and annually thereafter.  Owing to the heterogeneous nature of…

Director, Foundation for Diabetes Research in Older People (FDROP), Diabetes Frail Ltd
11:10 - 12:00

NETWORKING & EXHIBITION

12:05 - 12:35

Biosimilars explained – what is a biosimilar and should I prescribe them in practice?

Learning objectives: What is a biologic and a biosimilar? Consider the complexity of biologics and how biosimilars are different from generic medicines. How is a biosimilar different from the reference biologic, and how this compares with batch-to-batch variations within the reference medicine How are biosimilars developed? Consider the different stages including the comparative quality, non-clinical…

GP Partner & Medical Education & Scottish Lead, North Berwick Health Centre, GPwSI Diabetes, Primary Care Diabetes Society
12:40 - 13:10

Tips for safer acute care for patients with diabetes

Summary: An increasing number of people with diabetes are presenting to hospital acutely unwell It is highly likely that the first healthcare professional who assesses and initially manages the patient will not be specialist in diabetes Opportunities to ensure safe, effective diabetes care from early in the hospital admission process are not fully appreciated or…

Consultant in Diabetes & Senior Clinical Lecturer, University Hospital Southampton and University of Southampton
13:10 - 14:25

NETWORKING & EXHIBITION

14:30 - 15:30

The Live Debate


Speaker Details TBC

15:30 - 15:55

NETWORKING & EXHIBITION

15:55 - 16:25

Insulins Masterclass


Speaker Details TBC

This session has been organised and funded by Novo Nordisk.
16:30 - 17:00

Diabetes management – a pharmacist’s role


Consultant Diabetes Pharamacist, Southampton University Hospital
08:30 - 09:30

Registration

09:30 - 10:00

Keynote – Excellence across the care pathway: NICE and diabetes

NICE has produced over 40 pieces of guidance, advice and quality standards on every conceivable element of diabetes prevention, treatment and management. Find out how NICE’s recommendations are developed, and how they could help you to commission and provide high quality, person-centred care.

Chair, NICE (National Institute for Health and Care Excellence)
10:05 - 10:35

Flash glucose monitoring – from clinical practice to real world practice


Associate Professor & Consultant in Diabetes & Endocrinology, The Leeds Teaching Hospitals NHS Trust
11:10 - 12:00

NETWORKING & EXHIBITION

12:40 - 13:10

Choosing the right one – the technology toolkit

Using technology as an adjunct to education to support self-management for better clinical and psychosocial outcomes; working out which technology would be best for the individual and aligning your and your patient’s expectations. Learning outcomes: A problem-solving approach to identifying the most suitable technology at a given point in time Some psychosocial & clinical dimensions…

INPUT Patient Advocacy
INPUT Patient Advocacy
13:10 - 14:25

NETWORKING & EXHIBITION

14:30 - 15:30

The Live Debate


Speaker Details TBC

15:30 - 15:55

NETWORKING & EXHIBITION

15:55 - 16:25

Immersive learning: virtual, augmented and mixed reality

The objective of immersive learning is to create an experience where natural behaviors surface repeatedly through multiple iterations, which are subsequently followed by reflective conversations that trigger realisations.  Virtual, augmented and mixed realities enable these environments which can be used to enable and sustain behaviour change. Learn how immersive learning is being used in the diabetes…

CEO, Diabetes.co.uk
08:30 - 09:30

Registration

09:30 - 10:00

Keynote – Excellence across the care pathway: NICE and diabetes

NICE has produced over 40 pieces of guidance, advice and quality standards on every conceivable element of diabetes prevention, treatment and management. Find out how NICE’s recommendations are developed, and how they could help you to commission and provide high quality, person-centred care.

Chair, NICE (National Institute for Health and Care Excellence)
10:40 - 11:10

Why care about the exocrine pancreas in Diabetes Mellitus?


Associate Professor of Internal Medicine, Endocrinology & Diabetology, General Hospital Luebbecke-Rahden
This session is organised and remunerated by Mylan and is non-promotional
11:10 - 12:00

NETWORKING & EXHIBITION

12:05 - 12:35

Delaying and preventing diabetic retinopathy in primary care

Diabetic retinopathy is one of the most feared complications of diabetes as it can lead to blindness. I will discuss the natural history of diabetic retinopathy and the role of primary care in preventing and delaying progression of this microvascular complication. We will look at how retinal images are graded in screening and how the…

Senior Research Officer and Informatics Lead, Diabetes Research Unit, Cymru, Swansea University Medical School
12:40 - 13:10

Hot topics in diabetic kidney disease – a primary care perspective

The primary care management of diabetic kidney disease (DKD) is increasingly complex; I will distill the key take home messages from the NICE CKD guideline relevant to primary care and discuss the latest evidence guiding optimal glycemic targets in those with DKD.  Finally, I will provide an overview of the pharmacological management of hyperglycaemia in…

GP Partner with special interest in diabetes, Woodlands Medical Centre, Cardiff
13:10 - 14:25

NETWORKING & EXHIBITION

14:30 - 15:30

The Live Debate


Speaker Details TBC

15:30 - 15:55

NETWORKING & EXHIBITION

08:30 - 09:30

Registration

09:30 - 10:00

Keynote – Excellence across the care pathway: NICE and diabetes

NICE has produced over 40 pieces of guidance, advice and quality standards on every conceivable element of diabetes prevention, treatment and management. Find out how NICE’s recommendations are developed, and how they could help you to commission and provide high quality, person-centred care.

Chair, NICE (National Institute for Health and Care Excellence)
10:40 - 11:10

Improving outcomes for children with diabetes, lessons from the National Paediatric Diabetes Audit

The National Paediatric Diabetes Audit (NPDA) has collected data about process and outcomes for children and young people with diabetes living in England and Wales since 2003. No one would disagree that this is an essential component of driving quality improvement and leads to a better understanding of how delivery of care can be optimised.…

Paediatric Endocrinologist & Honorary Senior Lecturer University Hospital of Wales, Cardiff University
11:10 - 12:00

NETWORKING & EXHIBITION

12:05 - 13:10

Transition tightrope – supporting confident step change

This session looks at the best and not so optimal of the current systems used whilst transitioning care of a young person with diabetes from paediatric to adult services.  With speakers including consultants from paediatric and adult services, views from young people who’ve transitioned and families preparing their young person for transition, this session will…

Speaker Details TBC

13:10 - 14:25

NETWORKING & EXHIBITION

14:30 - 15:30

The Live Debate


Speaker Details TBC

15:30 - 15:55

NETWORKING & EXHIBITION

15:55 - 16:25

Using social media and tech to engage and empower younger patients


Consultant in Diabetes & Senior Clinical Lecturer, University Hospital Southampton and University of Southampton
08:30 - 09:30

Registration

09:30 - 10:00

Keynote – Excellence across the care pathway: NICE and diabetes

NICE has produced over 40 pieces of guidance, advice and quality standards on every conceivable element of diabetes prevention, treatment and management. Find out how NICE’s recommendations are developed, and how they could help you to commission and provide high quality, person-centred care.

Chair, NICE (National Institute for Health and Care Excellence)
10:40 - 11:10

A practical guide to low carbohydrate diabetes management – lessons from the Bermuda Triangle

The presentation will describe the benefits of carbohydrate restriction in type 2 diabetes, how it can help towards reversal of type 2 diabetes and practical tips on advising dietary change and adjusting medication. It will show how this approach leads to weight loss, lower HbA1c and less need for medication with examples from the diabetes…

Independent Consultant & Author
11:10 - 12:00

NETWORKING & EXHIBITION

12:05 - 12:35

Childhood obesity and T2 diabetes – spotting it early and tools for combatting

This presentation will highlight the methods used to identify weight gain and obesity in young people at risk of Type 2 diabetes and those already diagnosed. It will address the common challenges that are faced with achieving a healthy weight in this patient group and the approaches we are taking in Leeds to support and…

Paediatric Dietitian, Leeds Children’s Hospital
13:10 - 14:25

NETWORKING & EXHIBITION

14:30 - 15:30

The Live Debate


Speaker Details TBC

15:30 - 15:55

NETWORKING & EXHIBITION

10:05 - 10:35

Safe driving and diabetes – DVLA guidelines

There are 5 fatalities annually and up to 45 serious events every month associated with diabetes and driving. European guidance (2012) on diabetes and driving was taken up by the DVLA. This resulted in recommendations, which included that two hypoglycaemia events (day or night) in one year where 3rd party assistance was required would result…

Nurse Consultant- Diabetes, University Hospitals of Leicester NHS Trust, Associate Professor, University of Leicester, Co-Chair TREND-UK
10:40 - 11:10

Interpretation of BG data & profiles

Being presented with a record book with a wide range of blood glucose results can be daunting! Blood glucose monitoring should be a tool to facilitate a discussion about effective diabetes management between the person with diabetes and the healthcare professional supporting them. This session describes a simple process for identifying patterns in blood glucose…

Independent Diabetes Nurse Consultant, TREND-UK
12:40 - 13:10

Safe use of insulin

Biosimilar products are approved copies of biological medicines and can be developed once the patents for the original reference product has expired. The first biosimilar insulin was introduced into the UK market in 2015 and more are to be introduced in the next year. Biosimilar insulin is marketed at a lower cost than the original…

Specialist Practitioner Practice Nurse, South Kirkby West Yorkshire, TREND UK
14:30 - 15:15

Good Injection technique and Lipohypertrophy Screening inc Palpatation

This presentation will start by looking at the causes and impact of Lipohypertrophy. The presentation will include a live demonstration of the correct procedure for detecting and palpating lipohypertrophic lesions, there will then be the opportunity to examine a person with diabetes who injects to detect and palpate actual lipohypertrophic lesions. Learning outcomes: Describe what…

Nurse Consultant – Diabetes, Barnet Enfield & Haringey MHT, Co-Chair TREND-UK and Chair FIT UK
15:20 - 15:50

Diabetes care at end of life

As end of life approaches, the focus in diabetes management moves from reducing the risk of developing long-term complications to symptom control, the easing of targets and avoidance of acute complications. This session uses examples of people with type 1 and those with type 2 diabetes, with expected life of a year left to just…

Independent Diabetes Nurse Consultant, TREND-UK

Our site is intended for UK Healthcare Professionals

Are you a UK Healthcare Professional?

We’re sending you to our partner charity’s site. 

DRWF provide information and support for people with diabetes and their friends & families